Trial NCT00447265

View at ClinicalTrials.gov 
Org. Study IDs: DAIT ALN01

Last trial update was posted on 2013-02-12

MeSH Interventions

Etanercept

MeSH Conditions

Lupus Nephritis Nephritis

Other Conditions


Stopping Reasons

The perceived risk-benefit ratio for individuals with early active RA

Limitations And Caveats

The study terminated early with 1 subject enrolled. Based on safety info from other trials, the protocol chairs decided possible risks to patients outweighed the potential benefits. Analysis of groups is not possible. Study objectives cannot be met.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID